Genesis Unicorn Capital priced its initial public offering of 7.5 million units at $10 each. Units list on the Nasdaq and begin trading today under the ticker symbol GENQU. Each consists of one share of Class A common stock and a warrant. Once the securities begin separate trading, shares and warrants are expected to list under the symbols GENQ and GENQW.
Genesis Unicorn intends to focus its search on the intersection of the healthcare and technology industries, specifically within the biotechnology and pharmaceutical sectors.
EF Hutton is sole book-running manager for the offering. Read more.
